Similar articles

• Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man.

  Meikle AW, Jubiz W, Matsukura S, West CD, Tyler FH. Meikle AW, et al. J Clin Endocrinol Metab. 1969 Dec;29(12):1553-8. doi: 10.1210/jcem-29-12-1553. J Clin Endocrinol Metab. 1969. PMID: 4310497 No abstract available.
• [Ovulation inhibitors and ACTH reserve].

  Rindt W, Heinen G, Oertel GW. Rindt W, et al. Endokrinologie. 1971 Apr;57(3):358-63. Endokrinologie. 1971. PMID: 4325995 Clinical Trial. German. No abstract available.
• Adrenal-pituitary responsiveness during therapy with an oral contraceptive.

  Mestman JH, Anderson GV, Nelson DH. Mestman JH, et al. Obstet Gynecol. 1968 Mar;31(3):378-86. doi: 10.1097/00006250-196803000-00014. Obstet Gynecol. 1968. PMID: 4295678 No abstract available.
• Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Sequential changes during oral and intravenous metyrapone administration.

  Jubiz W, Matsukura S, Meikle AW, Harada G, West CD, Tyler FH. Jubiz W, et al. Arch Intern Med. 1970 Mar;125(3):468-71. Arch Intern Med. 1970. PMID: 4313727 No abstract available.
• [The thyroid gland, adrenal cortex and gonads--with reference to the metabolism of thyroid hormones, the adrenal cortex and sex steroid hormones].

  Ibayashi H. Ibayashi H. Saishin Igaku. 1967 Jul;22(7):1437-55. Saishin Igaku. 1967. PMID: 4295654 Review. Japanese. No abstract available.